Developmental Profile and Sexually Dimorphic Expression of Kiss1 and Kiss1r in the Fetal Mouse Brain by John Gabriel Knoll et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORIGINAL RESEARCH ARTICLE
published: 11 October 2013
doi: 10.3389/fendo.2013.00140
Developmental profile and sexually dimorphic expression
of Kiss1 and Kiss1r in the fetal mouse brain
John Gabriel Knoll 1, Colin M. Clay 2, Gerrit J. Bouma2,Timothy R. Henion3, Gerald A. Schwarting3,
Robert P. Millar 4,5,6 and Stuart A.Tobet 2,7*
1 Oregon Health and Science University, Portland, OR, USA
2 Biomedical Science, Colorado State University, Fort Collins, CO, USA
3 Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA
4 MRC Receptor Biology Unit, University of CapeTown, CapeTown, South Africa
5 Centre for Integrative Physiology, University of Edinburgh, Edinburgh, UK
6 Mammal Research Institute, University of Pretoria, Pretoria, South Africa
7 Biomedical Science and Biomedical Engineering, Colorado State University, Fort Collins, CO, USA
Edited by:
Pei-SanTsai, University of Colorado,
USA
Reviewed by:
Carol F. Elias, University of Michigan,
USA
Alexander S. Kauffman, University of
California San Diego, USA
Isabelle Franceschini, INRA, France
*Correspondence:
Stuart A. Tobet, Department of
Biomedical Sciences, Colorado State
University, 1617 Campus Delivery,
Fort Collins, CO 80523, USA
e-mail: stuart.tobet@colostate.edu
The hypothalamic-pituitary-gonadal axis (HPG) is a complex neuroendocrine circuit involv-
ing multiple levels of regulation. Kisspeptin neurons play essential roles in controlling the
HPG axis from the perspectives of puberty onset, oscillations of gonadotropin releasing
hormone (GnRH) neuron activity, and the pre-ovulatory LH surge.The current studies focus
on the expression of kisspeptin during murine fetal development using in situ hybridization
(ISH), quantitative reverse transcription real-time PCR (QPCR), and immunocytochemistry.
Expression of mRNA coding for kisspeptin (KISS1) and its receptor KISS1R was observed
at embryonic (E) day 13 by ISH. At E13 and other later ages examined, Kiss1 signal in indi-
vidual cells within the arcuate nucleus (ARC) appeared stronger in females than males. ISH
examination of agonadal steroidogenic factor-1 (Sf1) knockout mice revealed that E17 XY
knockouts (KO) resembled wild-type (WT) XX females. These findings raise the possibility
that gonadal hormones modulate the expression of Kiss1 in the ARC prior to birth.The sex
and genotype differences were tested quantitatively by QPCR experiments in dissected
hypothalami from mice at E17 and adulthood. Females had significantly more Kiss1 than
males at both ages, even though the number of cells detected by ISH was similar. In addi-
tion, QPCR revealed a significant difference in the amount of Kiss1 mRNA in Sf1 mice
with WT XY mice expressing less than XY KO and XX mice of both genotypes. The detec-
tion of immunoreactive KISS1 in perikarya of the ARC at E17 indicates that early mRNA is
translated to peptide. The functional significance of this early expression of Kiss1 awaits
elucidation.
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INTRODUCTION
The hypothalamic-pituitary-gonadal (HPG) axis is a complex
neuroendocrine circuit responsible for controlling physiological
and behavioral reproductive function. The classical description of
the circuit begins with gonadotropin releasing hormone (GnRH)
neurons, which reside in the basal forebrain/hypothalamus, secret-
ing GnRH into the hypophyseal portal vasculature where it is
transported to gonadotropes in the anterior pituitary (1,2). At least
one other cell type is now described as a regulatory component of
this circuitry (3). Cells that express the metastasis suppressor gene
Kiss1, whose protein product is commonly known as kisspeptin
(KISS1), reside in and around two specific locations in the hypo-
thalamus; the rostral periventricular portion of the pre-optic area
(POA; sometimes referred to as the RP3V for the rostral periven-
tricular area of the third ventricle), and the caudal region in and
around the arcuate nucleus (ARC) (4, 5). KISS1 stimulates GnRH
neuron activity and Kiss1/KISS1 expression and release is regu-
lated by circulating gonadal hormones (6, 7). All evidence to date
indicates that cells that synthesize KISS1 are functionally upstream
of GnRH neurons.
Much effort has gone into characterizing the role played by
KISS1 in the HPG axis. Work with targeted disruption of the
genes encoding KISS1 or its cognate receptor KISS1R has shown
that KISS1/KISS1R is essential for puberty and adult reproductive
competence (8–10). Two populations of kisspeptin neurons have
been identified. One population of neuronal cell bodies resid-
ing in the RP3V is responsible for mediating the pre-ovulatory
GnRH/LH surge and positive feedback actions of estradiol, while
the more caudal population around the ARC is responsible for
controlling the oscillatory GnRH pulses and negative feedback
actions of estradiol (11–13).
Data has revealed that in pre-pubertal and adult animals Kiss1
expression is regulated by estradiol and testosterone (7). Interest-
ingly, the regulation of Kiss1 is opposite in the different regions
that contain Kiss1 neurons. In the RP3V, steroid feedback is pos-
itive and up-regulates Kiss1 and in the ARC steroid feedback is
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negative and decreases Kiss1 (14). Several approaches involving
genetic modifications have been used to study hormonal influ-
ences on Kiss1, including mutations that preclude GnRH synthesis
(15), and those that preclude estradiol synthesis (16). The current
study takes advantage of transgenic mice in which the steroido-
genic factor-1 (Sf1) gene was disrupted. These Sf1 knockouts (KO)
mice do not develop fetal gonads and adrenal glands, and as such
there is no endogenous fetal sex-steroid production (17). This
enables us to determine if Kiss1 levels are regulated by sex steroid
in the fetal brain. Our hypothesis is that if gonadal steroids regu-
late fetal ARC Kiss1, Sf1 disrupted (KO) XY mice (that develop as
phenotypic females) should have more Kiss1 than wild-type (WT)
XY, and display expression levels similar to XX mice.
The goal of the current research was to determine the expres-
sion pattern of Kiss1 during fetal development and pre-pubertally,
as well as to assess Kiss1 levels in fetal agonadal mice. To accom-
plish this, both in situ hybridization (ISH) using digoxigenin
(DIG)-labeled riboprobes and real-time PCR quantitative reverse
transcription real-time PCR (QPCR) were used as complemen-
tary approaches to assess regional localization and expression
levels, respectively, in brain tissue collected from embryonic day
13 (E13) to post-natal day 35 (P35). Expression of Kiss1 and Kiss1r
was detected at E13 and maintained through puberty. Immuno-
histochemistry (IHC) in fetal and adult tissue revealed a KISS1
expression pattern similar to that of Kiss1, indicating mRNA is
translated into biologically active protein in early development. A
sex difference in Kiss1 expression was seen at specific fetal, post-
natal, and peri-pubertal ages, and levels in females always showed
significantly higher mRNA levels than males. Examining Kiss1 in
fetal brain tissue collected from agonadal Sf1 KO mice, revealed
Kiss1 mRNA expression in XY KO mice resembled WT XX more
than WT XY mice, supporting the hypothesis that the differenti-
ated gonad regulates sexual dimorphism in Kiss1 expression even
prior to birth.
MATERIALS AND METHODS
ANIMALS
GnRH-eGFP (17) and Sf1 KO (18) mice were housed in the
Painter Center of Laboratory Animal Resources at Colorado State
University and maintained in plastic cages with aspen bedding
(autoclaved Sani Chips, Harlan Teklad, Madison, WI, USA) and
environmental enrichments on a 14:10 h light:dark cycle with
free access to food (#8640, Harlan Teklad, Madison, WI, USA)
and tap water. Animal care and handling was in accordance with
the Colorado State University Animal Care and Use Committee
guidelines.
For fetal tissue collections, female and male mice were housed
together overnight, and the following day considered to be embry-
onic day 0 (E0) if vaginal plugs were observed. At the appro-
priate age, pregnant dams were deeply anesthetized with ket-
amine/xylazine (80 and 8 mg/kg, respectively), embryos were
removed individually by Cesarean section, and a crown-rump-
length measurement was taken to verify gestational age (approx-
imately 10 mm at E13, 14 mm at E15, and 19 mm at E17) (19).
GnRH-eGFP mice were homozygous for eGFP (CBB6/F1 back-
ground), and heterozygous Sf-1 mice (C57BL/6 background) were
bred to produce WT and KO embryos. Tissue from each fetus was
collected prior to perfusion for genotyping PCR using primers for
Sry to determine genetic sex, and primers for Sf1 to identify Sf1 KO
animals (20). After removal, each pup was perfused transcardially
with 2 ml 4% paraformaldehyde in 0.1 M phosphate buffer (PB;
pH= 7.4) using a hand held 10 ml syringe. Heads were post-fixed
overnight in fresh perfusion fixative then stored at 4°C in 0.1 M
PB prior to sectioning.
For post-natal tissues, post-natal day (P) 12 and P35 animals
were anesthetized with ketamine/xylazine (80 and 8 mg/kg, respec-
tively) and perfused with 10 ml Heparin/Saline followed by 10 ml
4% paraformaldehyde. Heads/brains were post-fixed overnight as
above and stored in 0.1 M PB prior to sectioning.
PROBES FOR IN SITU HYBRIDIZATION
The templates for generating DIG-labeled riboprobes to Kiss1 and
Kiss1r were obtained from Invitrogen Corporation as cDNAs in
the vector pT7T3-Pac, and prepared using DIG RNA labeling mix
(Roche Applied Sciences #11277073910) according to manufac-
turer’s instructions. Antisense riboprobes to Kiss1 were transcribed
from an EcoRI-linearized cDNA (GenBank accession #AA023588)
that includes the entire kisspeptin pre-protein coding sequence
(base pairs 38–416 of reference sequence NM_178260). Kiss1r
antisense riboprobes were generated from EcoRI-linearized cDNA
(accession #BF470621) complementary to base pairs 1716–2842
of Kiss1r reference sequence NM_053244), representing nearly the
entire Kiss1r coding sequence with the exception of 234 base pairs
within alternatively spliced exon 4. Sense probes were generated
from the same plasmids linearized with Not I. No reaction product
was observed in sections incubated with sense probes using ISH.
IN SITU HYBRIDIZATION
In situ hybridization was performed as described previously (21)
using free-floating tissue sections. Brains were embedded in 5%
agarose containing 1% diethyl pyrocarbonate (DEPC; Sigma,
D5758) and sectioned at 100µm using a vibrating microtome
(Leica VT1000s) and collected in 0.05 M phosphate buffered saline
(PBS) containing 1% DEPC. All sections from fetal brains were
collected in one mesh-bottomed container (referred to as a boat)
while sections from post-natal brains were alternated between two
boats. Sections were then treated with 6% hydrogen peroxide in
0.05 M PB containing 1% Tween-20 and 1% DEPC (PBT) for
1 h followed by three 5 min washes in PBT. After washing, sections
were treated with 10µg/ml proteinase K (Sigma, P2308) in PBT for
15 min, 10 min in 2 mg/ml glycine in PBT, and two 5 min washes in
PBT. Next, sections were post-fixed in 4% paraformaldehyde/0.2%
glutaraldehyde in PBT for 20 min and washed twice for 5 min in
PBT. All incubations and washes up to this point were done on a
shaker at room temperature. Following post-fixing, sections were
transferred to scintillation vials containing 2 ml of 50% formamide
in saline-sodium citrate (SSC; Sigma, S6639) buffer containing
8.8 U/ml heparin (Sigma, H9399), 0.05 mg/ml yeast tRNA (Sigma,
R5636), and 0.024 mg/ml dextran sulfate (Sigma, D8906) (collec-
tively pre-hybridization solution) for 1 h shaking at 60°C. DIG
labeled riboprobes (1µg/ml) were denatured by incubating for
5 min in an 85°C water bath and added to the vials contain-
ing the sections. Probes were hybridized overnight on a shaker
at 60°C.
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The following day, sections were transferred back into boats
and washed three times for 30 min in a 50% formamide/25% SSC
solution, then three times for 30 min in 50% formamide/10% SSC
(all while shaking at 60°C). Sections were then washed three times
for 5 min in Tris buffered saline (TBS) containing 1% Tween-
20 (TBST) then pre-blocked in 10% sheep serum in TBST for
1 h (shaking at room temperature). Sections were then incubated
overnight (while shaking at 4°C) in a solution of 1% sheep serum
in TBST containing alkaline phosphatase conjugated anti-DIG
antibody (Roche, 11093274910) at a concentration of 1:2000.
On the third day, sections were washed three times for 5 min,
then five times for 1 h in TBST on a shaker at room tempera-
ture, and incubated overnight at 4°C in TBST. On the final day,
sections were washed at room temperature three times for 15 min
in a solution of 0.1 M NaCl, 0.1 M Tris (pH= 9.5), 0.05 M MgCl2,
and 1% Tween-20 (collectively NTMT). Sections were then incu-
bated on a shaker in the dark at room temperature in a solution
containing 10% polyvinyl alcohol, 1 mM Levamisol (Vector Lab-
oratories, Burlingame, CA SP5000, USA), 2% NBT/BCIP (Roche,
11681451001), 0.1 M Tris (pH= 9.5), 0.1 M NaCl, and 0.005 M
MgCl2 (color detection mix). Sections were left in the color detec-
tion mix until dark purple reaction product was visible under
a dissecting microscope, at which point the reaction was termi-
nated for all tissues of the same age. To stop the color reaction,
sections were washed twice for 5 min in NTMT in the dark, incu-
bated in 0.1 M TBS containing 0.001 M EDTA for 30 min, and
finally twice for 10 min in PBT (on a shaker at room tempera-
ture). The procedures were designed to process all tissues at the
same time to facilitate qualitative comparisons between different
genotypes.
IMMUNOHISTOCHEMISTRY
Immunocytochemical procedures were standard and performed
as described previously (22). Briefly, 50µm serial sections from
4% paraformaldehyde perfusion-fixed peri-pubertal (P35) or
fetal (E17) brains were cut using a vibrating microtome (Leica
VT1000s) and collected into mesh-bottomed boats. Sections were
pretreated with 0.1 M glycine then 0.5% sodium borohydride in
0.05 M PBS. Sections were blocked with 5% normal goat serum
(NGS) and 1% hydrogen peroxide in 0.05 M PBS. Sections were
incubated with rabbit derived KISS1 antibody directed against
rodent kisspeptin-10 (provided by Dr. Alain Caraty) at a final
dilution of 1:10,000 for two nights (23). Primary antibody was
localized with a biotinylated donkey anti-rabbit secondary anti-
body (Jackson Immunoresearch, 711-065-152) used at a concen-
tration of 1:2500 for 2 h. Signal was amplified using the Vec-
tastain ABC Elite reagents (Vector Laboratories, PK6100) at a
concentration of 1:330 for 1 h. Finally, the reaction was visual-
ized using diaminobenzidine (DAB; 0.025%)/nickel ammonium
sulfate (0.2%) to produce a dark purple/black reaction prod-
uct. Although it has been reported that the antiserum does
not cross react with related RF-amide peptides such as RFRP-
1 and RFPR-3 (9, 10) this was not fully verified as some cells
were detected in regions such as the dorsomedial hypothalamus
where no cells were detected by ISH (Data not shown). Speci-
ficity of the IHC was established by omission of the primary
antibody.
DUAL-LABEL ISH/IHC
Dual-label ISH/IHC experiments were carried out exactly as
single-label experiments with the exception that the two protocols
were run in series. In this case, ISH for Kiss1r was performed
first, followed immediately by IHC for GnRH. Primary antibody
for these experiments was rabbit-anti-GnRH (Affinity Bioreagents
#PA1-121) used at a concentration of 1:200. For visualization, the
IHC was developed using Cy3-conjugated streptavidin (Jackson
Immunoresearch #016-160-084) at a concentration of 1:500.
QUANTITATIVE REVERSE TRANSCRIPTION REAL-TIME PCR
Tissue was collected fresh from fetuses (E17) and adults (∼P50)
and flash frozen on dry ice then stored at −80°C until homoge-
nized for RNA isolation. Brains were removed from GnRH-eGFP
and Sf1 KO mice in ice cold DEPC PBS. Genetic sex was con-
firmed by PCR for the presence of Sry. Pregnant mice were anes-
thetized with a mixture of Ketamine and Xylazine (80 and 8 mg/kg
respectively) and embryos were removed individually by Caesarian
section. Following brain removal, a hypothalamic block was dis-
sected (caudal to the optic chiasm and rostral to the mammillary
body) and a small (<10 mg) wedge of the mediobasal hypothal-
amus was collected for analysis by making a bilateral triangular
excision starting at the middle of the third ventricle and extend-
ing to the lateral boundary of the hypothalamus. Adult mice were
anesthetized with a mixture of Ketamine and Xylazine (80 and
8 mg/kg respectively) and the brains were dissected out, blocked
in the coronal plane rostral to the optic chiasm and caudal to the
mammillary bodies, then cut coronally midway between the optic
chiasm and the median eminence (ME) to divide the block into
rostral and caudal portions. For the rostral portion containing the
periventricular portion of the pre-optic area/anterior hypothala-
mus, a bilateral triangular excision was made extending from the
center of the anterior commissure to the basolateral boundary of
the hypothalamus. For the caudal portion containing the ARC,
an excision similar to that made for the embryos was collected.
At both ages cortical pieces were taken for negative controls in
the QPCR assays. All dissections were performed using a stereo
dissecting microscope.
RNA was isolated using the Qiagen RNeasy Mini Kit (Qiagen
Sciences, #74104). Briefly, excised brain pieces were pulverized
using a motorized tissue grinder and RNase free tubes and dis-
posable pestles (VWR cat. #47747-370 and #47747-366), then
homogenized in the supplied homogenization buffer and pro-
cedures were followed according to manufacturer’s instructions.
Once eluted, the RNA concentration and purity of each sample
was determined by spectrophotometry and samples were stored at
−80°C until reverse transcription (RT).
For GnRH-eGFP mice, RT was performed using the Thermo
Verso RT kit (Fisher cat #AB1453B) using random hexamer
primers for first strand synthesis according to manufacturer’s
instructions. For Sf1 KO mice, RT was performed using the qScript
cDNA Synthesis kit (Quanta Biosciences cat #95047) which con-
tains a mixture of random hexamers and oligo(dT). To insure
uniformity between samples, all RNA isolates were diluted to
100 ng/µl of which 5µl (500 ng total RNA) was added to each
20µl reaction. RT was performed less than 24 h prior to QPCR to
minimize potential sample degradation.
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For GnRH-eGFP animals, QPCR was performed using
HotStart-IT SYBR Green QPCR Master Mix (2X; USB Corpo-
ration, Cleveland, OH 75762, USA). According to the HotStart-IT
protocol, 20µl reactions were run of with 2µl cDNA. For Sf1
KO animals, QPCR was run using Light Cycler 480 SYBR Green
I Master Mix kit (Roche cat #04-707-516001) using 4µl cDNA in
each 20µl reaction. All QPCR experiments were performed in a
LightCycler 480 system (Roche Applied Sciences). Cycling para-
meters were as follows: hot start at 95°C for 1 min; 45 cycles of
amplification/quantification at 95°C for 10 s, 60°C for 30 s, and
72°C for 30 s during which time fluorescence was measured. Melt-
ing curve analysis was performed using continuous fluorescence
acquisition from 65–97°C. These cycling parameters generated
single amplicons for both primer sets used according to the pres-
ence of a single melt peak. Primers were designed to amplify
intron spanning regions of Kiss1 and Rn18s (reference gene) to
investigate the gene of interest and monitor amplification effi-
ciency. The two sets of primers used for this experiment were as
follows: Kiss1 forward 5′-TGATCTCAATGGCTTCTTGGCAGC-
3′ and reverse 5′-CTCTCTGCATACCGCGATTC CTTT-3′; Rn18s
forward 5′-AGGGGAGAGCGGGTAAGAGA-3′ and reverse 5′-
GGACAGGACTA GGCGGAACA-3′.
For absolute quantification of kisspeptin transcript, the same
plasmid used to generate the Kiss1 probe was used as a standard.
Since each plasmid contains a single copy of the Kiss1 gene, and
using an approximation of the total molecular weight of the plas-
mid (∼3.7E−12µg/copy) the concentration of plasmid was cal-
culated in terms of number of copies per µl of solution. A 10-fold
serial dilution series was used to generate a standard curve ranging
from∼1E11 copies/µl (0.4µg/µl) to∼100 copies/µl. This dilution
series was run in the same plate as each experiment and was used
to generate a standard curve from which the concentration (in
number of copies/well) was calculated for each sample. This num-
ber was then used to calculate the number of copies of Kiss1 in
E17 and adult male and female brains [copies/well÷ (microliter
cDNA/well)= copies/microliter cDNA÷ (microliter RNA/20µl
cDNA)= copies/microliter RNA×Dilution Factor= copies/
microliter RNA (undiluted)×Total RNA Volume=Total Copies/
dissection].
To control for contamination, several controls were used. First,
pieces of cortex not expected to express Kiss1 were collected from
each brain at the time of tissue collection. These tissues were
treated the same as all other tissue pieces and did not generate
a signal above background during QPCR. During the RT, two
additional controls were used; one reaction with no RNA, and
one with RNA (from an adult female rostral POA) but no reverse
transcriptase. Controls from each of the previous steps were run
through all subsequent steps. Real-time PCR controls included all
of the previous controls and one reaction containing no cDNA
(water control). None of the negative controls produced a signal
above background in QPCR (data not shown). Finally, standards
and samples were run in triplicate to verify accuracy; calculated
crossing point variance was below 2% for replicated samples.
STATISTICAL ANALYSIS
For each age group in each experiment three animals of each sex
and genotype from a minimum of two different litters were used
for quantitative analysis. To determine the number of cells express-
ing kisspeptin, all cells (with obvious nuclear voids) with visible
reaction product in all sections from a given brain were manually
counted at high magnification by an investigator blind to the sex
of each animal. For fetal brains this meant counting all sections
from the entire brain (all sections collected in a single boat) while
for older animals it meant counting all sections from half of the
brain (sections were alternated between two boats). The reason
for collecting all sections from the embryonic brains was to ensure
that important sections were not lost due to the smaller size of
the brains. For comparison purposes, the total number of cells
counted for each embryonic brain was divided in half to generate
the equivalent of the number of cells per half-brain. This method
was validated by alternating sections from a subset of fetal brains
into two boats and counting the number of cells per half-brain;
the resultant average was approximately equal to the average of
half the total cells per whole brain.
For QPCR, the crossing point was determined according to the
absolute quantification/second derivative maximum method in
the LightCycler 480 SW 1.5 software. From this number, the total
copy number was calculated based upon the previously described
standard curve. To verify the results of the standard curve absolute
quantification method, relative expression analysis was performed
by normalizing Kiss1 to Rn18s signal. Both methods generated
similar results and the absolute quantification method results were
selected for presentation. Cycling parameters were set up such that
the exponential amplification phase had been reached for all pos-
itive samples (45 cycles total). Any sample that did not exhibit an
appropriate amplification curve, a single melt curve, or that came
up after 40 cycles was assumed to be a false signal and was not ana-
lyzed. Negative control samples were never observed to generate a
signal before 40 cycles.
Statistical analysis was performed using SPSS 13.0 or JMP 10.0
for Mac OSX. For cell count analysis, the total number of cells
per half-brain and the sex of the animal were analyzed by two-
way ANOVA for sex and age. For QPCR data from Sf-1 embryos
two-way ANOVA for sex and genotype was used, with Least Square
Means Student’s t as a post hoc test. For adult animals, even though
there were two regions per animal, due to the greater variance in
the rostral/POA region compared to the caudal/ARC region, one-
way ANOVA was conducted on the rostral region separately from
a two-way analysis in the caudal/ARC region.
RESULTS
Kiss1/KISS1 AND Kiss1r REGIONAL LOCALIZATION IN THE FETAL BRAIN
Kiss1 was detected by ISH at E13 in a few cells (arrows in
Figure 1 left) near the ME. Two days later (E15) the total number
of cells expressing Kiss1 had greatly increased (from approxi-
mately 30 cells/half-brain to approximately 400 cells/half-brain),
although the distribution remained similar (Figure 1). Cells
containing Kiss1 were found in approximately eight sequential
sections, representing a distance of greater than 800µm in all ages
examined.
Expression of Kiss1r was detected at E13 in both sexes by ISH.
At this age, the only cells containing Kiss1r were found in the
nasal compartment in a pattern similar to the pattern of migrat-
ing GnRH neurons. By E15 a large proportion of this population
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FIGURE 1 | Kiss1 and Kiss1r are expressed as early as E13. Developmental
changes in the expression of Kiss1 (top four images) and Kiss1r (bottom four
images) are shown in digital images from sagittal sections of female mice at
E13 (left) and E15 (right). Smaller images are higher magnifications of the
same sections displayed immediately above them. Note the change in
location of the Kiss1r positive cells from the nasal compartment to the
forebrain between E13 and E15 reminiscent of the migrating GnRH neuron
population. Arrows indicate the location of mRNA positive cells. CP, cribriform
plate; Pit, pituitary; VNO, vomeronasal organ. Scale Bars: black=1 mm,
white=200µm.
of cells had apparently migrated to and across the cribriform plate
into the ventral forebrain (Figure 1), again suggestive of migrat-
ing GnRH neurons. With each successive age, the pattern of Kiss1r
expression matched the typical distribution of GnRH neurons,
with older animals having a high density of Kiss1r expression
around the diagonal band of Broca (DBB) and surrounding the
organum vasculosum of the lamina terminalis (OVLT) as well
as a more dispersed expression as far caudal as the optic chi-
asm. In addition, Kiss1r containing cells were seen in a highly
restricted population of cells in the habenula as early as E17 (data
not shown). No sex differences were observed in Kiss1r expressing
cells at any age or in any region (data not shown).
To verify that the cells seen to express Kiss1r in previous exper-
iments were GnRH neurons, dual-label ISH/IHC were performed
on E15 (Figure 2). As illustrated, GnRH immunoreactivity was
seen in a pattern corresponding to that of the Kiss1r expression
pattern at the same age (compare with Figure 1). High magnifi-
cation images of fluorescently labeled GnRH (B) and DIG labeled
Kiss1r (C) shows that, in fact, cells expressing Kiss1r at E15 were
migrating GnRH neurons.
To determine if Kiss1 is translated into processed KISS1
peptide during development, serial sections from fetal (E17)
brains were examined by IHC. Immunoreactive kisspeptin (KISS1;
Figures 3B,D) was detected using an antiserum raised against the
biologically active decapeptide. A similar distribution to that seen
using ISH was observed (Figures 3A,C). In fetal mice, KISS1 was
only found in a distribution of cells in the ARC, and cell bodies
were clearly identifiable in fetal ARC.
RELATIVE DIFFERENCES IN KISS1 LOCALIZATION PATTERNS IN MOUSE
FETAL AND EARLY POST-NATAL BRAIN
For the ages of E15 (Figure 2) and E17 (Figure 4) the pattern
of cells expressing Kiss1 remained unchanged. In addition, there
appeared no sex difference in the number of cells expressing Kiss1
(E15 not shown; E17, Figure 4). At P12, the number of cells
expressing Kiss1 was dramatically higher in the female compared
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FIGURE 2 | Co-localization of GnRH and Kiss1r in migrating neurons.
Kiss1r and GnRH were co-localized in migrating GnRH neurons in E15 mice.
(A) shows a digital image of a fluorescent IHC for GnRH in a sagittal section
from an E15 female also positive for Kiss1r. (B) (GnRH) and (C) (Kiss1r )
show higher magnification images of the boxed area in (A), with arrows to
indicate co-expressing cells. Compare the GnRH pattern in A to the Kiss1r
pattern seen in the bottom right corner of Figure 1. CP, cribriform plate; OB,
olfactory bulb. Scale Bars: white=500µm, black= 100µm.
to the male. This is the only age examined at which there was a sig-
nificant sex difference in the detectable number of cells expressing
Kiss1 in and around the ARC [Figure 4; F(1,4)= 8.2, p< 0.05].
There was no sex difference in the number of cells expressing Kiss1
at E13, E15, E17, or P35 (Figure 4).
In rostral sections, Kiss1 was first detected using ISH in a few
cells at P12 (Figure 5). As with the more caudal ARC population,
there was a distribution of cells in the rostral sections that begins
near the opening of the third ventricle and extends caudally in a
continuous cluster beyond the level of the anterior commissure.
For the entire distribution, Kiss1 was found in cell bodies along
a narrow periventricular strip noted as the rostral periventricular
region of the third ventricle (RP3V) (4). At P12 there was not a sta-
tistically significant sex difference in the number of cells found in
the rostral population of cells. At P35 there appeared dramatically
more cells in RP3V sections in both sexes as well as a significant sex
difference in the number of cells found in these sections [Figure 5;
F(1,4)= 262.0, p< 0.01], but no difference in the total number of
cells in the ARC sections [Figure 5; F(1,4)= 1.83, p= 0.25].
SEX DIFFERENCES IN ABSOLUTE Kiss1 AMOUNT IN FETAL AND ADULT
MOUSE BRAIN
Quantitative reverse transcription real-time PCR was used to
assess the absolute level of Kiss1 in E17 and P50 (young adult) male
and female GnRH-eGFP mice. As previous results suggested, and
in agreement with the current ISH data, adult females expressed
nearly four times as much Kiss1 as males in the RP3V [Figure 6;
F(1,4)= 9.77; p< 0.05]. In the caudal hypothalamic region of the
adult animals, females were found to express more than twice
as much transcript as males [Figure 6; F(1,4)= 43.1, p< 0.01]. A
similar difference was found in the E17 animals, when Kiss1 expres-
sion is restricted to the caudal region around the ARC, with females
expressing more than twice as much Kiss1 as males [Figure 6;
F(1,6)= 22.1; p< 0.01]. Females were not examined at the time
of dissection to determine estrous stage. In a final comparison, and
in agreement with the increase in cell count with age, the level of
Kiss1 expression was significantly different between fetal and adult
animals [Figure 6; age effect: F(1,10)= 41.01, p< 0.01; sex by age
effect; F(1,10)= 10.26, p< 0.01].
POTENTIAL SOURCE OF SEX DIFFERENCES IN Kiss1 IN FETAL MOUSE
BRAIN
To determine if the sex difference of Kiss1 in ARC neurons was
related to steroid hormones or gonadal status of fetal mice, we
conducted Kiss1 ISH analyses of Sf1 KO XY mice (agonadal due to
disruption of the Sf1 gene but genetically male) compared with XY
and XX WT littermates. Sf1 KO mice die shortly after birth due to
the absence of adrenal hormones, and thus without glucocorticoid
supplementation these animals can only be evaluated at embryonic
ages (24, 25). However, the advantage of using these animals is that
the effects of total gonadal ablation can be achieved from the earli-
est stage of development, before surgical gonadectomy is possible.
In each experiment, sections from Sf1 KO XY mice were most
comparable to sections from WT XX mice by qualitative visual
inspection of the optical density of reaction product (Figure 7).
Cells observed in sections from WT XY mice were consistently
lighter in color than either WT XX or XY Sf1 KO mice.
To verify that the visual ISH difference represents an actual
difference in Kiss1, QPCR was performed on cDNA from hypo-
thalamic tissue dissections from E17 XY and XX Sf1 KO and
WT littermates. There was a sex difference in Kiss1 copy num-
ber between XY and XX WT mice from the Sf1 KO line (p< 0.05
post hoc) that was similar to the results from the previous QPCR
experiments using GnRH-eGFP animals. Importantly, there was
a significant sex by genotype interaction [Figure 7; F(1,8)= 6.56;
p= 0.034] with XY WT mice expressing significantly less Kiss1
than XY KO, but with no difference between XX WT and XX KO.
Thus the impact of the KO was only seen in males that may have
had functional gonads.
DISCUSSION
An increasing number of studies have indicated the importance of
kisspeptin signaling for both the onset of puberty and the promo-
tion of normal adult reproduction (1, 26). Several have demon-
strated the sex-steroid dependence of peri-pubertal changes in
Kiss1 expression and sexually dimorphic Kiss1 expression in the
rostral hypothalamus (11, 27). However, despite the pre-pubertal
sex differences in circulating sex steroids, most notably at certain
perinatal “critical periods,” until recently few studies have investi-
gated the early developmental expression of Kiss1 and its cognate
receptor KISS1R (12, 28).
In the last few years a growing body of research has begun to
shed light on the emerging understanding that the kisspeptin sys-
tem is actively regulated long before puberty. Several recent reports
have examined the expression of Kiss1 early in life. In a study of
the ontogeny of kisspeptin neurons using BrdU birth dating in
rats, these neurons differentiate locally within the region of the
ARC beginning around E12.5 (29). Kiss1 was present in hypothal-
amic micropunches and KISS1 immunoreactive cells and fibers
were detected as early as E14.5. Importantly, by showing that the
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FIGURE 3 | Embryonic distribution of Kiss1/KISS1 expressing
cells. Digital images of representative sections showing the
rostral-caudal distribution of cells expressing Kiss1 (A) and
kisspeptin-10 immunoreactivity (B) in the ARC. Expression extends
over 800–1000µm. High magnification digital montages, taken from
coronal plane 2 in (A,B), highlight differences in cell detail such as
nuclear voids in ISH reaction product (C), but not IHC (D). Scale bars:
(A,B)=500µm; (C,D)=250µm.
number of cells increased early in development (E14.5–18.5) and
then decreased (E18.5–22.5) the data suggests pre-natal regulation
of the kisspeptin system. Similar to these results, Kiss1 expressing
neurons were detected via ISH soon after birth (first reported for
P3) in the ARC of rats and there were transient sex differences in
the number of Kiss1 cells, with females having significantly more
cells at certain times than their male littermates (30). Finally, in
mice examined for Kiss1 expression on the day of birth, both the
number of Kiss1 positive cells and the amount of Kiss1 per cell
were higher in females than males (31). Interestingly, by exam-
ining the levels of circulating testosterone and using transgenic
models with disrupted kisspeptin or GnRH signaling, the authors
demonstrated that sex differences in gonadal steroid production
arise independent of KISS1/KISS1R and GnRH.
In the current series of experiments, Kiss1 and Kiss1r were
detected in E13 mouse brain tissue. Using IHC it was further
demonstrated that Kiss1 is translated into immunoreactive pep-
tide as early as E17 and potentially earlier. This result is similar to
findings of pre-natal kisspeptin expression in rats (29). The dif-
ferences with our results, most notably that a small number of
KISS1 IR cells and fibers were found in the RP3V pre-natally in
rats, are likely due to species variation or differences in detection
technique. The current results replicate earlier studies showing the
sexually dimorphic number of Kiss1 expressing cells in the ARC
and RP3V of mice and rats (5, 31, 32), but importantly show that
there is already a sexually dimorphic pattern within the fetal ARC,
whether examined qualitatively by visual inspection of colorimet-
ric ISH (see Figure 7) or quantitatively using QPCR. Our data
show sex differences in the amount of ARC Kiss1 at all ages exam-
ined, with RP3V expression only detected after birth. By using
Sf1 KO mice that do not develop gonads, the early dependence of
Kiss1 levels on gonadal status is strongly suggested. Although it
is possible that knocking out Sf1 causes changes in Kiss1 expres-
sion in gonad independent manner – such as preventing signaling
within the mediobasal hypothalamus itself – this is unlikely con-
sidering that XX knockouts (KO) were not significantly different
from their WT littermates. The demonstration of regulated Kiss1
expression early in development suggests functional relevance that
merits further investigation.
In an effort to better understand the development of sex dif-
ferences in the brain’s reproductive axis, the developmental profile
of Kiss1 expression using ISH was determined. Expression of Kiss1
was found at E13 followed by a dramatic increase in the number
of detectable cells positive for Kiss1 by E15. This increase demon-
strates an early expression of Kiss1, and also suggests a temporally
coordinated up-regulation. From E15 to P0 there was no signifi-
cant change in either the number of cells found to express Kiss1 or
in the distribution pattern of these cells around the ARC (i.e.,∼400
cells/half-brain distributed over∼800µm rostrocaudally). Protein
translation from Kiss1 was verified by IHC for KISS1 in E17 and
adult animals where immunoreactive product was seen in a pattern
similar to that seen with ISH. At all ages examined, mRNA coding
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FIGURE 4 | Developmental changes in cells expressing Kiss1 in
the region of the ARC. The number of cells expressing Kiss1 in and
around the ARC differs with age (n=3 per group) shown in coronal
sections. A transient sex difference in the number of ARC cells was
evident at P12 (mean±SEM; *p<0.01). Note the difference in the
optical density of reaction product between males (images in the
right column) and females (left column). This difference is most visibly
evident at P12 and P35 but is notable at all ages examined at higher
magnification. Pit, pituitary; 3V, third ventricle, ME, median eminence.
Scale bar=100µm.
for the kisspeptin receptor KISS1R also was detected. The presence
of both the ligand and cognate receptor establishes the possibility
that a functional signaling system exists not only prior to puberty,
but also well before birth. KISS1R is highly selective for kisspeptin
when compared with all other RF-amide peptides. Similar to pre-
vious results, at E13 these cells were found exclusively in the nasal
compartment in a distribution pattern that strongly resembles
the migrating GnRH neuron population (33). Co-localization of
immunoreactive GnRH and Kiss1r in E15 animals confirmed that
cells seen to contain Kiss1r are, in fact, migrating GnRH neurons.
Unfortunately, the absence of verified antibodies against KISS1R
prevented the examination of the translation status of KISS1R.
Projections from neurons in the ARC may develop relatively late
(34, 35). This would make ARC KISS1 an unlikely source of ligand
for migrating GnRH neurons at embryonic ages, particularly when
they are in the nasal compartment expressing Kiss1r. Previous
results showing the efficacy of peripheral kisspeptin administra-
tion suggest that systemic, endocrine-like signaling, as opposed
to synaptic release, could potentially play a role in development
(36). Other peripheral sources of kisspeptin are possible (e.g., pla-
centa), which would suggest that signaling is not for the purpose
of providing a directional cue for migrating GnRH neurons but
could possibly influence axon targeting (37). Similar to previous
findings, one additional population of Kiss1r expressing cells was
found in the habenula (38). These cells are located at the approxi-
mate border of the medial and lateral divisions of the habenula and
were seen from E17 on (though not noted in younger animals).
It is interesting to note the role of the habenula in physiological
changes related to seasonality and specifically in seasonal breeders
(36, 39, 40). While it remains to be determined where the ligand
would come from to reach cells in the habenula expressing KISS1R,
one possible source is the“estrogen concentrating cells”of the POA
that send projections to the habenula (41–43). This also raises the
possibility that patients with inactivating mutations of KISS1R or
KISS1 may exhibit phenotypes other than those manifested in the
reproductive system.
The data from older animals in the current study confirms the
pattern of Kiss1 expression that has been reported previously (5,
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FIGURE 5 | Expression of Kiss1 in the RP3V. Digital images (left) of coronal
sections show that Kiss1 in the RP3V was first detected at P12. A dramatic
sex difference in the number of cells expressing Kiss1 was evident around
the time of puberty onset in females, P35 (see graphs on the right; n=3 per
group; mean±SEM; *p< 0.01). 3V, third ventricle; OC, optic chiasm, AC,
anterior commissure; Scale bar=500µm.
15, 44). Specifically, Kiss1 was observed in the ARC in both sexes
at all post-natal ages in a pattern very similar to the fetal pattern.
At P12 there was a significant sex difference in the number of
Kiss1 expressing cells in the ARC, with females having more cells
than males. Since the number of cells in males is similar to that
of females by the next time point (P35) it could simply indicate a
sex difference in maturational rate, which would not be unusual
for the development of brain characteristics (45). Similarly, it is
possible that all post-natal sex differences observed in the ARC
are due to differences in circulating sex steroids; several studies
have shown that sex differences in Kiss1 expression in the RP3V
are eliminated in mice and rats that have artificially equal levels of
sex steroids (5, 14). Interestingly, P12 is the first age at which Kiss1
expression was detected in a few cells in rostral sections. This result
is similar to previously published research showing detection of
Kiss1 at P10 (32). At this age, possibly due to the apparently low
level of message or the relatively low number of cells, there was no
sex difference in the number of Kiss1 containing cells seen in the
RP3V. By contrast, at around the time of puberty onset (P35) there
was a dramatic sex difference in the number of Kiss1 expressing
cells in the RP3V, with females having far more cells than males.
In the current study, data from three different approaches sug-
gest that the level of Kiss1 in the ARC is a reliable sex difference
in development and adulthood. First, qualitative differences were
noted between males and females based on the optical density of
ISH reaction product. Second, quantitative QPCR produced com-
plementary results. The complementary nature of both ISH and
QPCR assay was particularly evident at E17. Although the number
FIGURE 6 | Sex and age differences in Kiss1 expression. The visual sex
difference in the amount of Kiss1 detected by ISH in hypothalamic tissue
was confirmed by QPCR. There was a significant difference in total copy
number between males and females at both ages in the ARC and in the
RP3V of adults. In addition, a post hoc analysis showed a significant
difference in the amount of Kiss1 between adults and embryos in the ARC
(n=3 for each group; data is mean±SEM; *p<0.05, **p<0.01).
of cells positive for Kiss1 in the ARC appeared similar according
to ISH, females had absolute levels of Kiss1∼twofold greater than
males according to QPCR and this difference remained at P35.
As a verification of the method, the sex difference in adult Kiss1
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Knoll et al. Kisspeptin development in fetal mouse brain
FIGURE 7 | Pre-natal Kiss1 expression is gonad dependent. Digital
images of coronal sections in (A) show that E17 Sf1 KO XY resemble WT
XX more than WT XY mice by qualitative inspection of ISH reaction product.
QPCR quantification of Kiss1 (B) reveals a significant effect of sex by
genotype with WT males expressing less Kiss1 than KO males or females
of either genotype (n=3 per group; mean±SEM. After a significant
interaction between sex and genotype, *p<0.05 indicates a specific of XY
KO to XX WT. 3V, third ventricle; ME, median eminence. Scale bar=100µm.
levels within the more rostral RP3V was approximately fourfold
as expected from data in reports for either whole hypothalamus
or RP3V, respectively (28, 46). It should be noted that the adult
females used for QRCR experiments were not examined to deter-
mine which stage of the estrous cycle they were in at the time
of sacrifice, nor were circulating levels of sex steroids measured
in either males or females. It has been established that Kiss1 levels
depend on levels of circulating sex steroids and varies dramatically
during the estrous cycle in both RP3V and ARC (47). It is possible
that the observed sex differences are due, fully or in part, to dif-
ferences in circulating levels of sex steroids. Finally, as many sex
differences in adulthood are the direct result of differences in the
steroid environment of the fetus (48), agonadal Sf1 KO mice were
used to further test the gonadal steroid dependence of pre-natal
Kiss1 expression. The intensity of ISH reaction product revealed
that Sf1 KO XY mice were more similar to XX WT rather than XY
WT mice, suggesting that the level of Kiss1 expression is directly
dependent on the gonadal status and presumably the pre-natal
steroid environment.
Pre-natal sexual differentiation of the rodent brain is largely
driven by testosterone produced by the developing testes that
is converted to estradiol within the brain itself. Female fetuses
are protected from masculinization and defeminization by cir-
culating alpha-fetoprotein which binds circulating estrogens and
prevents it from acting in the brain (49). Based on the find-
ing that estradiol administration to adult animals decreases ARC
Kiss1 expression while increasing expression in the RP3V (5,
14), it is reasonable to speculate that testosterone derived estra-
diol inhibits Kiss1 expression in male fetuses. This also implies
that there is another mechanism in addition to estradiol stim-
ulation that drives expression of kisspeptin in the RP3V as no
rostral Kiss1 expression was detected in any animals, regardless of
genotype, prior to P12. If estradiol signaling were the only dri-
ving force for RP3V expression, it would be reasonable to expect
expression in fetal males. Previous studies have shown that the
RP3V kisspeptin expressing population can be decreased by estra-
diol administration at birth (50, 51) or increased by neonatal
castration (46), as well as decreased by gonadectomy later dur-
ing pre-pubertal development (27). This may indicate that the
RP3V population becomes sensitized to estradiol later during
development and that other developmental events are required
prior to puberty.
In summary, Kiss1 and Kiss1r were detected in fetal mice early
in development. Kiss1r was co-localized with GnRH in the nasal
compartment and rostral forebrain during GnRH neuron migra-
tion,while Kiss1 was found selectively in cells within the developing
ARC. At E17 KISS1 was observed in the same region and distri-
bution as the mRNA. Kiss1 expression was both qualitatively and
quantitatively sexually dimorphic, and likely related to hormone
exposure prior to birth. The sex difference in this region is main-
tained into adulthood, although the exact cause and function of
this early kisspeptin expression remains to be elucidated.
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